What is BillionToOne, Inc. 's cumulative cost basis?

BillionToOne, Inc. (BLLN) reported cumulative cost basis of $43.63M in Q4 2025.

BillionToOne, Inc. BLLN Cumulative Cost Basis

Cumulative Cost Basis at other companies

Guardant HealthGH

——

Natera, Inc.NTRA

——

Tempus AI, Inc.TEM

——

Lantheus HoldingsLNTH

——

IncyteINCY

——

Tango TherapeuticsTNGX

——

Other financials

Income statement

See full

Revenue$108.4M+83.8%

Gross profit$79.1M+108%

Operating income$17.8M+870%

Net income$18.0M+551%

EPS (diluted)$0.34+187%

Balance sheet

See full

Cash & equivalents$537.5M+181%

Total debt$144.2M—

Total equity$505.6M+300%

Total assets$700.7M—

Cash flow

See full

Operating cash flow$15.4M+488%

CapEx$4.5M+90.5%

Free cash flow$11.0M+3,842%

Valuation

See full

Market cap$4.84B—

Enterprise value$4.44B—

P/E163.1×—

P/S13.6×—

Profitability

See full

Gross margin70.4%—

Operating margin-96.9%—

Net margin8.4%—

FCF margin-83.4%—

Returns & leverage

See full

Return on equity23.5%—

Debt / equity0.3×—

Current ratio10.9×—

Where this comes from

Reported directly by BillionToOne, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentGross.

The official record: BillionToOne, Inc. ’s 10-K, filed March 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about BillionToOne, Inc. 's cumulative cost basis.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is BillionToOne, Inc. 's cumulative cost basis?: BillionToOne, Inc. (BLLN) reported cumulative cost basis of $43.63M in Q4 2025.